Tamir Biotechnology, Inc. 4
4 · Tamir Biotechnology, Inc. · Filed Jul 25, 2012
Insider Transaction Report
Form 4
KENYON LAWRENCE A
CEO, CFO
Transactions
- Award
Common Stock (Right to Buy)
2012-07-23+400,000→ 400,000 totalExercise: $0.04Exp: 2022-07-23→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]Issued under the Company's 2004 Stock Incentive Plan and qualified under Rule 16b-3(d)
- [F2]25% of these options vest and become exercisable immediately, the grant date; 25% vest and become exercisable January 23, 2013; 25% vest and become exercisable July 23, 2013; and 25% vest and become exercisable January 23, 2014.